X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (272) 272
Patent (74) 74
Conference Proceeding (63) 63
Publication (19) 19
Book Review (15) 15
Music Score (10) 10
Streaming Audio (9) 9
Dissertation (4) 4
Book / eBook (2) 2
Book Chapter (2) 2
Magazine Article (1) 1
Reference (1) 1
Technical Report (1) 1
Trade Publication Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (126) 126
humans (121) 121
clinical neurology (99) 99
female (75) 75
aged (74) 74
male (73) 73
chemistry (64) 64
alzheimer's disease (57) 57
human necessities (57) 57
hygiene (57) 57
medical or veterinary science (57) 57
metallurgy (56) 56
organic chemistry (56) 56
peptides (56) 56
preparations for medical, dental, or toilet purposes (56) 56
physics (55) 55
calculating (47) 47
computing (47) 47
counting (47) 47
middle aged (45) 45
data processing systems or methods, specially adapted foradministrative, commercial, financial, managerial, supervisoryor forecasting purposes (42) 42
neurosciences (42) 42
systems or methods specially adapted for administrative,commercial, financial, managerial, supervisory or forecastingpurposes, not otherwise provided for (42) 42
alzheimer disease - drug therapy (40) 40
abridged index medicus (35) 35
dementia (35) 35
clinical trials (30) 30
aged, 80 and over (29) 29
neurology (26) 26
neuropsychological tests (23) 23
alzheimer disease - diagnosis (20) 20
alzheimer disease - psychology (20) 20
alzheimers-disease (20) 20
double-blind method (20) 20
geriatrics & gerontology (19) 19
mild cognitive impairment (19) 19
brain (18) 18
clinical trials as topic (18) 18
diagnosis (17) 17
disease progression (16) 16
drug therapy (16) 16
magnetic resonance imaging (16) 16
pathology (16) 16
adult (15) 15
article (14) 14
immunotherapy (14) 14
mathematics (14) 14
psychiatry (14) 14
treatment outcome (14) 14
alzheimer disease - physiopathology (13) 13
alzheimer’s disease (13) 13
severity of illness index (13) 13
alzheimer disease - therapy (12) 12
alzheimers disease (12) 12
alzheimer disease - pathology (11) 11
follow-up studies (11) 11
gastroenterology & hepatology (11) 11
united states (11) 11
alzheimer disease (10) 10
animals (10) 10
atrophy (10) 10
brain - pathology (10) 10
clinical trial (10) 10
medicine, general & internal (10) 10
mri (10) 10
nootropic agents - therapeutic use (10) 10
rating-scale (10) 10
aging (9) 9
amyloid beta-peptides - metabolism (9) 9
biomarkers (9) 9
classical music (9) 9
longitudinal studies (9) 9
medicine & public health (9) 9
risk (9) 9
risk factors (9) 9
specific therapeutic activity of chemical compounds ormedicinal preparations (9) 9
alzheimer disease - genetics (8) 8
alzheimer disease - prevention & control (8) 8
amyloid (8) 8
aniline compounds (8) 8
care and treatment (8) 8
double-blind (8) 8
health aspects (8) 8
psychiatric status rating scales (8) 8
research (8) 8
alzheimer disease - diagnostic imaging (7) 7
alzheimer disease - metabolism (7) 7
analysis (7) 7
antibodies (7) 7
cognition disorders - drug therapy (7) 7
dose-response relationship, drug (7) 7
general tagging of cross-sectional technologies spanning over several sections of the ipc (7) 7
general tagging of new technological developments (7) 7
geriatrics/gerontology (7) 7
medical research (7) 7
microbiology (7) 7
national institute (7) 7
nutrition & dietetics (7) 7
positron-emission tomography (7) 7
prevalence (7) 7
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (401) 401
French (23) 23
German (11) 11
Chinese (9) 9
Polish (9) 9
Spanish (5) 5
Czech (3) 3
Portuguese (3) 3
Hebrew (2) 2
Japanese (2) 2
Korean (2) 2
Arabic (1) 1
Croatian (1) 1
Danish (1) 1
Greek (1) 1
Hungarian (1) 1
Russian (1) 1
Serbian (1) 1
Slovenian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet Neurology, ISSN 1474-4422, 2012, Volume 11, Issue 3, pp. 241 - 249
Journal Article
Molecular Psychiatry, ISSN 1359-4184, 09/2014, Volume 19, Issue 9, pp. 1044 - 1051
Journal Article
Journal of Number Theory, ISSN 0022-314X, 08/2014, Volume 141, p. 214
We prove that the Diophantine equation NX.sup.2+2.sup.L3.sup.M=Y.sup.N has no solutions (N,X,Y,L,M) in positive integers with N1 and gcd(NX,Y)=1, generalizing... 
Mathematics - Number Theory
Journal Article
JOURNAL OF NUMBER THEORY, ISSN 0022-314X, 08/2014, Volume 141, pp. 214 - 224
We prove that the Diophantine equation NX2 + 2(L)3(M) = Y-N has no solutions (N, X, Y, L, M) in positive integers with N > 1 and gcd(NX, Y) = 1, generalizing... 
MATHEMATICS | Exponential Diophantine equations | Lehmer sequences | PRIMITIVE DIVISORS | LUCAS
Journal Article
Neurology, ISSN 0028-3878, 10/2012, Volume 79, Issue 16, pp. 1636 - 1644
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 01/2014, Volume 370, Issue 4, pp. 322 - 333
In two phase 3 trials in patients with Alzheimer's disease, bapineuzumab, a humanized anti–amyloid-beta monoclonal antibody, did not improve clinical outcomes.... 
ANTIBODIES | MEDICINE, GENERAL & INTERNAL | EPITOPE | IMAGING ABNORMALITIES | PEPTIDE | MOUSE MODEL | Phosphorylation | Humans | Middle Aged | Male | Positron-Emission Tomography | Treatment Failure | Aged, 80 and over | Amyloid beta-Peptides - cerebrospinal fluid | Female | Severity of Illness Index | Antibodies, Monoclonal, Humanized - adverse effects | Antibodies, Monoclonal, Humanized - therapeutic use | Double-Blind Method | Biomarkers - analysis | Alzheimer Disease - drug therapy | tau Proteins - cerebrospinal fluid | Alzheimer Disease - cerebrospinal fluid | Cognition - drug effects | Neuropsychological Tests | Amyloid beta-Peptides - antagonists & inhibitors | Apolipoproteins E - genetics | Intention to Treat Analysis | Amyloid beta-Peptides - analysis | Brain - pathology | Aged | Biomarkers - cerebrospinal fluid | Edema - chemically induced | Alzheimer Disease - genetics | Monoclonal antibodies | Product development | Research | Drug therapy | Alzheimer's disease | Health aspects | Edema | Nuclear magnetic resonance--NMR | Intravenous administration | Neurodegenerative diseases | Cognitive ability | Clinical trials | Cerebrospinal fluid | Apolipoproteins | Patients | Studies | Tau protein | Apolipoprotein E | Immunotherapy | Alleles | Dementia disorders | Alzheimers disease | Index Medicus | Abridged Index Medicus | Brain | Neurosciences | pathology | Biological Markers | Antibodies | Cognition | tau Proteins | 80 and over | genetics | Amyloid beta-Peptides | Apolipoproteins E | Monoclonal | Neurovetenskaper | drug therapy | chemically induced | Humanized | drug effects | Alzheimer Disease | analysis | antagonists & inhibitors | cerebrospinal fluid | adverse effects | therapeutic use
Journal Article